郭胜杰 - 中山大学 - 肿瘤防治中心

个人简介

教育及工作经历 2011.08 至今中山大学肿瘤防治中心　泌尿外科 2009.07-2010.12 美国马里兰大学医学院　博士联合培养 2006.09-2011.07 中山大学附属第一医院　泌尿外科硕博连读 2001.09-2006.06 武汉大学医学院临床医学

研究领域

泌尿系肿瘤(肾癌，膀胱癌、前列腺癌、肾盂输尿管肿瘤、肾上腺肿瘤以及腹膜后肿瘤、睾丸癌、阴茎癌等)的外科治疗

近期论文

查看导师最新文章（温馨提示：请注意重名现象，建议点开原文通过作者单位确认）

1.Shengjie Guo, Xue Y, He Q, Preoperative serum cystatin-C as a potential biomarker for prognosis of renal cell carcinoma. PLoS One. 2017 Jun 6;12(6):e0178823（第一） 2.Li Z, Shengjie Guo, Wu Z, Subclassification of pN3 staging systems for penile cancer: Proposal for modification of the current TNM classification. Urol Oncol. 2017;35(9):543.e1-543（共一） 3.3. Xiaobo He# ,Shengjie Guo# . Preoperative Albumin to Globulin Ratio (AGR) as Prognostic Factor in Renal Cell Carcinoma J. Cancer 2017; 8(2): 258-265. (共一) 4.Shengjie Guo He X, Chen Q, The C-reactive protein/albumin ratio, a validated prognostic score, predicts outcome of surgical renal cell carcinoma patients.BMC Cancer. 2017 Mar 6;17(1):171. （第一） 5.Shengjie Guo, Xiaobo He, , Qian Chen,,.The Effect of Preoperative Apolipoprotein A-I on the Prognosis of Surgical Renal Cell Carcinoma: A Retrospective Large Sample Study. Medicine (Baltimore). 2016 ;95(12):e3147. （第一） 6.Xiangdong Li#,Shengjie Guo#,Zhiming Wu, Surveillance for patients with clinical stage I nonsemino atous testicular germ cell tumors. World J Urol. 2015;33(9):1351-7. (共一) 7 .Guo,S et al The expression and function of ETK in bladder cancer，PLoS One. 2011 Mar 7;6(3):e17778 8.Guo,S et al Overexpression of Pim-1 in bladder cancer, J. Exp. Clin. Cancer Res 2010 Dec 11;29(1):161 9.Dai, B., Chen, H., Guo, S. et al. Compensatory upregulation of tyrosine kinase Etk/BMX in response to androgen deprivation promotes castration-resistant growth of prostate cancer cells. Cancer Res 2010, 70(13), 5587-5596